FY2024 Earnings Estimate for Avantor Issued By William Blair

Avantor, Inc. (NYSE:AVTR) – Equities researchers at William Blair dropped their FY2024 earnings per share (EPS) estimates for Avantor in a research report issued to clients and investors on Monday, October 28th. William Blair analyst M. Larew now forecasts that the company will post earnings per share of $0.98 for the year, down from their previous forecast of $1.02. The consensus estimate for Avantor’s current full-year earnings is $1.01 per share. William Blair also issued estimates for Avantor’s Q4 2024 earnings at $0.25 EPS, Q3 2025 earnings at $0.30 EPS and Q4 2025 earnings at $0.34 EPS.

Several other analysts have also issued reports on AVTR. Royal Bank of Canada reiterated an “outperform” rating and set a $34.00 price objective on shares of Avantor in a report on Thursday, September 26th. TD Cowen raised their target price on Avantor from $28.00 to $31.00 and gave the company a “buy” rating in a report on Monday, July 29th. Evercore ISI cut their target price on Avantor from $28.00 to $27.00 and set an “outperform” rating on the stock in a report on Tuesday, July 2nd. Barclays cut their target price on Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a report on Friday, October 25th. Finally, Wells Fargo & Company cut their target price on Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a report on Monday. Three investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $27.57.

Avantor Stock Performance

Shares of Avantor stock opened at $22.52 on Tuesday. The company has a quick ratio of 1.05, a current ratio of 1.59 and a debt-to-equity ratio of 0.89. Avantor has a 12 month low of $16.63 and a 12 month high of $28.00. The business has a fifty day simple moving average of $25.38 and a 200-day simple moving average of $24.22. The stock has a market cap of $15.30 billion, a PE ratio of 57.74, a price-to-earnings-growth ratio of 2.93 and a beta of 1.33.

Insider Buying and Selling

In related news, CAO Steven W. Eck sold 3,525 shares of Avantor stock in a transaction dated Thursday, September 5th. The stock was sold at an average price of $25.06, for a total transaction of $88,336.50. Following the sale, the chief accounting officer now directly owns 29,544 shares of the company’s stock, valued at $740,372.64. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.50% of the stock is owned by company insiders.

Institutional Investors Weigh In On Avantor

Institutional investors have recently added to or reduced their stakes in the company. Versant Capital Management Inc boosted its holdings in Avantor by 2,003.6% during the second quarter. Versant Capital Management Inc now owns 1,157 shares of the company’s stock valued at $25,000 after purchasing an additional 1,102 shares in the last quarter. Blue Trust Inc. boosted its holdings in Avantor by 1,830.3% during the second quarter. Blue Trust Inc. now owns 1,467 shares of the company’s stock valued at $31,000 after purchasing an additional 1,391 shares in the last quarter. UMB Bank n.a. acquired a new stake in Avantor during the third quarter valued at approximately $49,000. Nisa Investment Advisors LLC boosted its holdings in Avantor by 69.6% during the third quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company’s stock valued at $53,000 after purchasing an additional 835 shares in the last quarter. Finally, GAMMA Investing LLC boosted its holdings in Avantor by 89.9% during the third quarter. GAMMA Investing LLC now owns 2,715 shares of the company’s stock valued at $70,000 after purchasing an additional 1,285 shares in the last quarter. 95.08% of the stock is owned by institutional investors and hedge funds.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.